Lyell Immunopharma, Inc.LYELNASDAQ
LOADING
|||
Switch Symbol:
Debt to Assets Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Debt-to-assets ratio
Latest
0.12
↑ 62% above average
Average (5y)
0.07
Historical baseline
Range
High:0.12
Low:0.05
CAGR
+19.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 0.12 | +42.6% |
| 2023 | 0.08 | +16.6% |
| 2022 | 0.07 | +20.0% |
| 2021 | 0.06 | +0.1% |
| 2020 | 0.06 | +21.5% |
| 2019 | 0.05 | - |